Literature DB >> 18491171

Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.

Marianne Debrunner1, Ernst Schuiki, Elisabeth Minder, Edwin Straumann, Barbara Naegeli, Raymond Mury, Osmund Bertel, Jürgen Frielingsdorf.   

Abstract

BACKGROUND: Inflammatory response is an important feature of acute coronary syndromes and myocardial infarction (MI). The prognostic value of proinflammatory cytokines in patients with acute MI complicated by cardiogenic shock is unknown. METHODS AND
RESULTS: In 41 patients admitted with acute MI (age 60 +/- 11 years, six females, 19 Killip class IV) serial plasma concentration of tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and interleukin 1 receptor antagonist (IL-1Ra) were measured. Seven patients with cardiogenic shock (CS) developed a systemic inflammatory response syndrome (SIRS). Patients with CS-particularly those who developed SIRS-showed significantly higher cytokine levels than patients with uncomplicated MI. In patients with CS and SIRS peak levels of IL-1Ra were 223,973 pg/ml, IL-6 252.8 pg/ml and TNF-alpha 7.0 pg/ml. In CS without SIRS IL-1Ra levels were 19,988 pg/ml, IL-6 109.3 pg/ml and TNF-alpha 3.8 pg/ml. In uncomplicated MI peak IL-1Ra levels were 1,088 pg/ml, IL-6 34.1 pg/ml and TNF-alpha 2.6 pg/ml.
CONCLUSIONS: The inflammation-associated cytokines TNF-alpha, IL-6 and IL-1Ra are significantly elevated in patients with MI complicated by CS when compared to patients with uncomplicated MI. Among shock-patients IL-1Ra levels are promising diagnostic markers for early identification of patients developing SIRS, heralding a poor outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18491171     DOI: 10.1007/s00392-007-0626-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  32 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

Review 2.  Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

Authors:  S Akira; T Hirano; T Taga; T Kishimoto
Journal:  FASEB J       Date:  1990-08       Impact factor: 5.191

3.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study.

Authors:  A Sturk; C E Hack; L A Aarden; M Brouwer; R R Koster; G T Sanders
Journal:  J Lab Clin Med       Date:  1992-05

5.  Production of interleukin-1-receptor antagonist during experimental endotoxaemia.

Authors:  E V Granowitz; A A Santos; D D Poutsiaka; J G Cannon; D W Wilmore; S M Wolff; C A Dinarello
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.

Authors:  G Torre-Amione; S Kapadia; J Lee; J B Durand; R D Bies; J B Young; D L Mann
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells.

Authors:  P Ghezzi; C A Dinarello; M Bianchi; M E Rosandich; J E Repine; C W White
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

9.  Elevated levels of interleukin-6 in unstable angina.

Authors:  L M Biasucci; A Vitelli; G Liuzzo; S Altamura; G Caligiuri; C Monaco; A G Rebuzzi; G Ciliberto; A Maseri
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Adipose tissue: the new endocrine organ? A review article.

Authors:  Susan E Wozniak; Laura L Gee; Mitchell S Wachtel; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

2.  Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium.

Authors:  Claudius Jacobshagen; Theresa Pelster; Anja Pax; Wiebke Horn; Stephan Schmidt-Schweda; Bernhard W Unsöld; Tim Seidler; Stephan Wagner; Gerd Hasenfuss; Lars S Maier
Journal:  Clin Res Cardiol       Date:  2010-02-04       Impact factor: 5.460

3.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

Review 4.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

5.  Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction.

Authors:  C Meisinger; M Heier; W von Scheidt; B Kuch
Journal:  Clin Res Cardiol       Date:  2010-07-02       Impact factor: 5.460

6.  Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients.

Authors:  Lennaert Kleijn; B Daan Westenbrink; Vincent M van Deursen; Kevin Damman; Rudolf A de Boer; Hans L Hillege; Dirk J van Veldhuisen; Adriaan A Voors; Peter van der Meer
Journal:  Clin Res Cardiol       Date:  2014-02-08       Impact factor: 5.460

7.  Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Roland Prondzinsky; Susanne Unverzagt; Henning Lemm; Nikolas-Arne Wegener; Axel Schlitt; Konstantin M Heinroth; Sebastian Dietz; Ute Buerke; Patrick Kellner; Harald Loppnow; Martin G Fiedler; Joachim Thiery; Karl Werdan; Michael Buerke
Journal:  Clin Res Cardiol       Date:  2012-01-03       Impact factor: 5.460

8.  Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.

Authors:  Bernhard Richter; Marianne Gwechenberger; Ariel Socas; Gerlinde Zorn; Sulaima Albinni; Manfred Marx; Jutta Bergler-Klein; Thomas Binder; Johann Wojta; Heinz D Gössinger
Journal:  Clin Res Cardiol       Date:  2011-11-19       Impact factor: 5.460

9.  Acute regional left atrial ischemia causes acceleration of atrial drivers during atrial fibrillation.

Authors:  Masatoshi Yamazaki; Uma Mahesh R Avula; Krishna Bandaru; Auras Atreya; Venkata Subbarao C Boppana; Haruo Honjo; Itsuo Kodama; Kaichiro Kamiya; Jérôme Kalifa
Journal:  Heart Rhythm       Date:  2013-02-21       Impact factor: 6.343

10.  Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality.

Authors:  Jiri Parenica; Jan Malaska; Jiri Jarkovsky; Jolana Lipkova; Milan Dastych; Katerina Helanova; Jiri Litzman; Josef Tomandl; Simona Littnerova; Jana Sevcikova; Roman Gal; Pavel Sevcik; Jindrich Spinar; Monika Pavkova Goldbergova
Journal:  Exp Clin Cardiol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.